| |
|
|
|
Rigel Pharmaceuticals  
|
|
1.955 -0.075 (-0.04%) |
05-29 16:00 |
|
Open: |
2.01 |
Pre close: |
2.03 |
Target:
|
2.45
|
|
High: |
2.02 |
Low: |
1.9 |
Resistance:
|
2.10
2.45
|
|
Volume: |
1,414,645 |
Market Cap: |
330M |
Support:
|
1.73
 1.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.97
|
MACD |
MACD(12,26):
|
0.07  |
|
MA(20): |
1.88 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
1.98 |
Stochastic Oscillator |
%K(14,3):
|
80.67 |
|
MA(250): |
2.04 |
%D(3): |
79.18 |
|
Average Volume(K) |
3-Month: |
152208
|
52-Week |
High:
|
3.10 |
|
10-Days: |
143811 |
Low: |
1.23 |
|
RSI |
RSI(14):
|
55.41 |
Change(%): |
-8.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.167 |
Return on Equity (ttm) |
-32.3 |
Shares Out. (M) |
168.57 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-11.7 |
Shares Float (M) |
168.05 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.31 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
341.7 |
% Held by Institutions |
90.42 |
|
Forward EPS |
-0.400 |
Gross Profit (p.s.) |
0.033 |
Shares Short (K) |
14560 |
|
Book Value (p.s.) |
0.470 |
EBITDA (p.s.) |
-0.172 |
P/E |
-11.71 |
|
Sales Per Share |
0.608 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.16 |
|
Profit Margin |
-27.39 |
Operating Cash Flow
(M) |
-44.03 |
P/S |
3.22 |
|
Operating Margin |
-28.98 |
Levered Free Cash Flow
(M) |
-16.66 |
P/CF |
-7.48 |
|
|
|
|
|
|
